FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2276471607> ?p ?o ?g. }

• W2276471607 abstract "14538 Background: PMGCT are uncommon germ cell malignancies. Mediastinal nonseminomatous germ cell tumors (NSGCT) have a poor prognosis, whereas pure seminoma (Sem) has a good or intermediate prognosis irrespective of mediastinal presentation. Methods: We retrospectively identified 19 male pts with PMGCT seen at MDACC between October 1998 and September 2004 from a clinical database. Pts with resectable NSGCT were offered surgery upon plateau of their chemotherapy response. Prior to referral, 1 pt had primary surgical resection without preoperative (preop) chemotherapy. Results: There were 14 pts with NSGCT and 5 with good prognosis Sem. The median age was 29.5 (20–60). Seven pts with NSGCT had mixed or undifferentiated histology, and the remainder had pure yolk sac (5 pts) or choriocarcinoma (2 pts). The estimated median survival (Kaplan-Meier) for all patients (Sem + NSGCT) was 21 months. All pts with Sem were alive and disease-free at last follow-up (median 12 months, range 7–34). All pts with Sem received 4 courses of etoposide and cisplatin (EP); one also received bleomycin (BEP); one received radiotherapy consolidation; none received surgery. Of the pts with NSGCT, 9 (64%) have died, including 1 who refused surgery. Five pts with NSGCT were alive at last follow-up and 3 (21%) were disease-free (15+, 27+ and 35+ months). Four pts with NSGCT (29%) reached beyond 2 years survival (27+, 28, 35+, and 63+ months) including 3 with lung metastases and one with elevated preop alpha-fetoprotein (28,022 ng/ml). Each of these pts received 6–10 courses of multiple-regimen preop chemotherapy, and 2 received initially 4 courses of BEP without marker normalization. Conclusions: Mediastinal Sem treated with 4 courses EP had an excellent outcome without surgery. Pts with mediastinal NSGCT had a 64% mortality rate despite aggressive treatment. Several pts with mediastinal NSGCT did achieve long-term survival following aggressive chemotherapy and surgery, even with lung metastases and failure to normalize markers. A phase III trial of BEP versus dose-dense chemotherapy for poor-prognosis NSGCT is now in progress at MDACC. No significant financial relationships to disclose." @default.
• W2276471607 created "2016-06-24" @default.
• W2276471607 creator A5016909082 @default.
• W2276471607 creator A5027897588 @default.
• W2276471607 creator A5030797960 @default.
• W2276471607 creator A5057758356 @default.
• W2276471607 creator A5058115259 @default.
• W2276471607 creator A5076621000 @default.
• W2276471607 creator A5082402405 @default.
• W2276471607 date "2006-06-20" @default.
• W2276471607 modified "2023-09-27" @default.
• W2276471607 title "Treatment outcomes of patients (pts) with primary mediastinal germ cell tumors (PMGCT): The M. D. Anderson Cancer Center (MDACC) experience" @default.
• W2276471607 doi "https://doi.org/10.1200/jco.2006.24.18_suppl.14538" @default.
• W2276471607 hasPublicationYear "2006" @default.
• W2276471607 type Work @default.
• W2276471607 sameAs 2276471607 @default.
• W2276471607 citedByCount "0" @default.
• W2276471607 crossrefType "journal-article" @default.
• W2276471607 hasAuthorship W2276471607A5016909082 @default.
• W2276471607 hasAuthorship W2276471607A5027897588 @default.
• W2276471607 hasAuthorship W2276471607A5030797960 @default.
• W2276471607 hasAuthorship W2276471607A5057758356 @default.
• W2276471607 hasAuthorship W2276471607A5058115259 @default.
• W2276471607 hasAuthorship W2276471607A5076621000 @default.
• W2276471607 hasAuthorship W2276471607A5082402405 @default.
• W2276471607 hasConcept C121608353 @default.
• W2276471607 hasConcept C126322002 @default.
• W2276471607 hasConcept C143998085 @default.
• W2276471607 hasConcept C185592680 @default.
• W2276471607 hasConcept C2776694085 @default.
• W2276471607 hasConcept C2776938808 @default.
• W2276471607 hasConcept C2779463800 @default.
• W2276471607 hasConcept C502942594 @default.
• W2276471607 hasConcept C71924100 @default.
• W2276471607 hasConcept C8010536 @default.
• W2276471607 hasConceptScore W2276471607C121608353 @default.
• W2276471607 hasConceptScore W2276471607C126322002 @default.
• W2276471607 hasConceptScore W2276471607C143998085 @default.
• W2276471607 hasConceptScore W2276471607C185592680 @default.
• W2276471607 hasConceptScore W2276471607C2776694085 @default.
• W2276471607 hasConceptScore W2276471607C2776938808 @default.
• W2276471607 hasConceptScore W2276471607C2779463800 @default.
• W2276471607 hasConceptScore W2276471607C502942594 @default.
• W2276471607 hasConceptScore W2276471607C71924100 @default.
• W2276471607 hasConceptScore W2276471607C8010536 @default.
• W2276471607 hasLocation W22764716071 @default.
• W2276471607 hasOpenAccess W2276471607 @default.
• W2276471607 hasPrimaryLocation W22764716071 @default.
• W2276471607 hasRelatedWork W1996533072 @default.
• W2276471607 hasRelatedWork W2055222271 @default.
• W2276471607 hasRelatedWork W2065894135 @default.
• W2276471607 hasRelatedWork W2078125348 @default.
• W2276471607 hasRelatedWork W2091883565 @default.
• W2276471607 hasRelatedWork W2119963083 @default.
• W2276471607 hasRelatedWork W2418070221 @default.
• W2276471607 hasRelatedWork W2418486715 @default.
• W2276471607 hasRelatedWork W2424108965 @default.
• W2276471607 hasRelatedWork W3082457214 @default.
• W2276471607 isParatext "false" @default.
• W2276471607 isRetracted "false" @default.
• W2276471607 magId "2276471607" @default.
• W2276471607 workType "article" @default.